[1] |
Wallis RS, Pai M, Menzies D , et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet, 2010,375(9729):1920-1937.
doi: 10.1016/S0140-6736(10)60359-5
URL
pmid: 20488517
|
[2] |
Wallis RS, Kim P, Cole S , et al. Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect Dis, 2013,13(4):362-372.
doi: 10.1016/S1473-3099(13)70034-3
URL
|
[3] |
Koguchi Y, Kawakami K, Uezu K , et al. High plasma osteopontin level and its relationship with interleukin-12-media-ted type 1 T-helper cell response in tuberculosis. Am J Respir Crit Care Med, 2003,167(10):1355-1359.
doi: 10.1164/rccm.200209-1113OC
URL
pmid: 12574077
|
[4] |
Andersen P, Munk ME, Pollock JM , et al. Specific immunebased diagnosis of tuberculosis. Lancet, 2000,356(9235):1099-1104.
doi: 10.1016/s0140-6736(00)02742-2
URL
pmid: 11009160
|
[5] |
Sester M, Sotgiu G, Lange C , et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J, 2011,37(1):100-111.
doi: 10.1183/09031936.00114810
URL
|
[6] |
Ruhwald M, Bodmer T, Maier C , et al. Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J, 2008,32(6):1607-1615.
doi: 10.1183/09031936.00055508
URL
pmid: 18684849
|
[7] |
Hong JY, Jung GS, Kim H , et al. Efficacy of inducible protein 10 as a biomarker for the diagnosis of tuberculosis. Int J Infect Dis, 2012,16(12):e855-859.
doi: 10.1016/j.ijid.2012.07.013
URL
pmid: 22959355
|
[8] |
魏兰, 秦学博, 段小亮 , 等. 血干扰素诱导蛋白10检测对判断肺结核患者治疗效果的价值. 中国防痨杂志, 2019,41(2):181-185.
|
[9] |
Cole KE, Strick CA, Paradis TJ , et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med, 1998,187(12):2009-2021.
doi: 10.1084/jem.187.12.2009
URL
pmid: 9625760
|
[10] |
Loetscher P, Pellegrino A, Gong JH , et al. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem, 2001,276(5):2986-2991.
doi: 10.1074/jbc.M005652200
URL
pmid: 11110785
|
[11] |
中华人民共和国国家卫生和计划生育委员会.WS 288—2017 肺结核诊断. 2017 -11-09.
|
[12] |
Groom JR, Luster AD . CXCR3 in T cell function. Exp Cell Res, 2011,317(5):620-631.
doi: 10.1016/j.yexcr.2010.12.017
URL
pmid: 21376175
|
[13] |
Sakai S, Kauffman KD, Schenkel JM , et al. Cutting edge: control of Mycobacterium tuberculosis infection by a subset of lung parenchyma-homing CD4 T cells. J Immunol, 2014,192(7):2965-2969.
doi: 10.4049/jimmunol.1400019
URL
pmid: 24591367
|
[14] |
Arlehamn CL, Seumois G, Gerasimova A , et al. Transcriptional profile of tuberculosis antigen-specific T-cells reveals novel multifunctional features. J Immunol, 2014,193(6):2931-2940.
doi: 10.4049/jimmunol.1401151
URL
pmid: 25092889
|
[15] |
Ottenhoff TH . New pathways of protective and pathological host defense to mycobacteria. Trends Microbiol, 2012,20(9):419-428.
doi: 10.1016/j.tim.2012.06.002
URL
|
[16] |
Yang CS, Lee JS, Lee HM , et al. Differential cytokine levels and immunoreactivities against Mycobacterium tuberculosis antigens between tuberculous and malignant effusions. Respiratory Medicine, 2008,102(2):280-286.
doi: 10.1016/j.rmed.2007.08.016
URL
pmid: 17933504
|
[17] |
Azzurri A, Sow OY, Amedei A , et al. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microb Infect, 2005,7(1):1-8.
doi: 10.1016/j.micinf.2004.09.004
URL
pmid: 15716076
|
[18] |
Riou C, Perez Peixoto B, Roberts L , et al. Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis. PLoS One, 2012,7(5):e36886.
doi: 10.1371/journal.pone.0036886
URL
pmid: 22606304
|
[19] |
Bhattacharyya C, Majumder PP, Pandit B . CXCL10 is overexpressed in active tuberculosis patients compared to M.tuberculosis-exposed household contacts. Tuberculosis, 2018,109:8-16.
doi: 10.1016/j.tube.2018.01.005
URL
pmid: 29559124
|
[20] |
Nonghanphithak D, Reechaipichitkul W, Namwat W , et al. Chemokines additional to IFN-γ can be used to differentiate among, Mycobacterium tuberculosis, infection possibilities and provide evidence of an early clearance phenotype. Tuberculosis, 2017,105:28-34.
doi: 10.1016/j.tube.2017.04.005
URL
pmid: 28610785
|
[21] |
Chung W, Lee K, Jung Y , et al. Serum CXCR3 ligands as biomarkers for the diagnosis and treatment monitoring of tuberculosis. Int J Tuberc Lung Dis, 2015,19(12):1476-1484.
doi: 10.5588/ijtld.15.0325
URL
pmid: 26614189
|
[22] |
Lee K, Chung W, Jung Y , et al. CXCR3 ligands as clinical markers for pulmonary tuberculosis. Int J Tuberc Lung Dis, 2015,19(2):191-199.
doi: 10.5588/ijtld.14.0525
URL
pmid: 25574918
|
[23] |
Young CW, Dukyong Y, Sung LK , et al. The Usefulness of Serum CXCR3 Ligands for Evaluating the Early Treatment Response in Tuberculosis:A Longitudinal Cohort Study. Medicine, 2016,95(17):e3575.
doi: 10.1097/MD.0000000000003575
URL
pmid: 27124069
|
[24] |
Chung WY, Lee KS, Yun JJ , et al. A TB Antigen-Stimulated CXCR3 Ligand Assay for the Diagnosis of Active Pulmonary TB. Chest, 2014,146(2):283-291.
doi: 10.1378/chest.13-1855
URL
|
[25] |
Groom JR, Luster AD . CXCR3 in T cell function. Experimental Cell Research, 2011,317(5):620-631.
doi: 10.1016/j.yexcr.2010.12.017
URL
|
[26] |
Whiting D, Hsieh G, Yun JJ , et al. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production. J Immunol, 2004,172(12):7417-7424.
doi: 10.4049/jimmunol.172.12.7417
URL
pmid: 15187119
|
[27] |
Heise CE, Pahuja A, Hudson SC , et al. Pharmacological Characterization of CXC Chemokine Receptor 3 Ligands and a Small Molecule Antagonist. J Pharmacol Exp Ther, 2005,313(3):1263-1271.
doi: 10.1124/jpet.105.083683
URL
pmid: 15761110
|
[28] |
Loetscher P, Pellegrino A, Gong JH , et al. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem, 2001,276(5):2986-2991.
doi: 10.1074/jbc.M005652200
URL
pmid: 11110785
|
[29] |
Lohmann EM , Koster BF, le Cessie S, et al. Grading of a positive sputum smear and the risk of Mycobacterium tuberculosis transmission. Int J Tuberc Lung Dis, 2012,16(11):1477-1484.
doi: 10.5588/ijtld.12.0129
URL
pmid: 22964038
|
[30] |
Rotondi M, Lazzeri E, Romagnani P , et al. Role for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field. J Endocrinol Invest, 2003,26(2):177-180.
doi: 10.1007/bf03345149
URL
pmid: 12739748
|
[31] |
Tworek D, Kuna P, Mlynarski W , et al. MIG (CXCL9), IP-10(CXCL10) and I-TAC (CXCL11) concentrations after nasal allergen challenge in patients with allergic rhinitis. Arch Medical Sci, 2013,9(5):849-853.
doi: 10.5114/aoms.2013.37198
URL
pmid: 24273568
|
[32] |
Alessandri AL, Souza AL, Oliveira SC , et al. Concentrations of CXCL8, CXCL9 and sTNFR1 in plasma of patients with pulmonary tuberculosis undergoing treatment. Inflam Res, 2006,55(12):528-533.
doi: 10.1007/s00011-006-5136-9
URL
pmid: 17039284
|
[33] |
Singh B, Anbalagan S, Selvaraj P . Regulatory role of CCL5 (rs2280789) and CXCL10 (rs56061981) gene polymorphisms on intracellular CCL5 and CXCL10 expression in pulmonary tuberculosis. Hum Immunol, 2017,78(5/6):430-434.
doi: 10.1016/j.humimm.2017.03.008
URL
pmid: 28336310
|
[34] |
Cole KE, Strick CA, Paradis TJ , et al. Interferon-inducible T Cell Alpha Chemoattractant (I-TAC): A Novel Non-ELR CXC Chemokine with Potent Activity on Activated T Cells through Selective High Affinity Binding to CXCR3. J Exp Med, 1998,187(12):2009-2021.
doi: 10.1084/jem.187.12.2009
URL
pmid: 9625760
|